Clinical Trials Directory

Trials / Completed

CompletedNCT04051151

Move to Improve Physical Activity in Parkinson's Disease

Move to Improve Physical Activity in Parkinson's Disease: MoTIvatE PD

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Apathy is a multi-dimensional behavior characterized by impairments to motivation, planning and initiation; collectively called, goal-directed behavior. It is highly prevalent in patients suffering from neurological disorders such as Alzheimer's disease and Parkinson's disease (PD) as well as psychiatric disorders such as depression and schizophrenia. In PD, specifically, apathy is one of the more troublesome symptoms. Apathetic PD patients have greater disability, lower adherence to treatment plans and caregivers report greater stress and burden. Interventions grounded in behavioral economic theories, namely, financial and social incentives often promote positive behavioral change such as weight loss and smoking cessation. However, the effectiveness of these interventions varies across and within conditions and incentive type. It also tends to dissipate when incentives are no longer provided. To date, these approaches have not been used to promote behavior change in PD or other neurological conditions where apathetic behaviors are a pressing problem. The overall goal of this study is to test if behavioral economic approaches will reduce apathy, and subsequently, improve goal-directed behavior in Parkinson's disease.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGameficiationParticipants and partners that have randomized to the gamification group will receive instructions and help in setting up a game platform via Way to Health. This game will include wearing a Fit Bit device, setting a daily step goal, and point deductions for failure to meet this step goal throughout the following 4 weeks. Participants will move up or down specified levels each week depending on how many days they met their step goal.

Timeline

Start date
2019-08-26
Primary completion
2020-01-01
Completion
2023-12-01
First posted
2019-08-09
Last updated
2024-01-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04051151. Inclusion in this directory is not an endorsement.